Cargando…

Features of atrial fibrillation in wild‐type transthyretin cardiac amyloidosis: a systematic review and clinical experience

AIMS: Wild‐type transthyretin (ATTRwt) cardiac amyloidosis has emerged as an important cause of heart failure in the elderly. Atrial fibrillation (AF) commonly affects older adults with heart failure and is associated with reduced survival, but its role in ATTRwt is unclear. We sought to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mints, Yuliya Y., Doros, Gheorghe, Berk, John L., Connors, Lawreen H., Ruberg, Frederick L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165925/ https://www.ncbi.nlm.nih.gov/pubmed/29916559 http://dx.doi.org/10.1002/ehf2.12308

Ejemplares similares

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities
por: Staron, Andrew, et al.
Publicado: (2020)

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
por: Papathanasiou, Maria, et al.
Publicado: (2022)

Cooperative Stabilization of Transthyretin by Clusterin and Diflunisal
por: Greene, Michael J., et al.
Publicado: (2014)

Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis
por: Mendelson, Lisa, et al.
Publicado: (2022)

Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study
por: Staron, Andrew, et al.
Publicado: (2021)

Induced Pluripotent Stem Cell Modeling of Multisystemic, Hereditary Transthyretin Amyloidosis
por: Leung, Amy, et al.
Publicado: (2013)

Comparison of right ventricular involvement in AL and transthyretin-type cardiac amyloidosis by cardiovascular magnetic resonance
por: Appelbaum, Evan, et al.
Publicado: (2009)

Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study
por: Madhani, Avni, et al.
Publicado: (2023)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis
por: Martini, Nicolò, et al.
Publicado: (2020)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Wild-Type Transthyretin Cardiac Amyloidosis in a Transplanted Heart
por: Stern, Lily K., et al.
Publicado: (2023)

Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis
por: Bandera, Francesco, et al.
Publicado: (2022)

Hepatocyte Growth Factor and Cardiac Amyloidosis
por: Ruberg, Frederick L., et al.
Publicado: (2020)

Multimodality assessments of wild‐type transthyretin cardiac amyloidosis with no ventricular hypertrophy
por: Iwaya, Takuma, et al.
Publicado: (2022)

Wild-type transthyretin amyloidosis in female patients
por: Kristen, Arnt V, et al.
Publicado: (2015)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis
por: Ihse, Elisabet, et al.
Publicado: (2010)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
por: Versteylen, Mathijs O., et al.
Publicado: (2022)

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients
por: Wange, Niklas, et al.
Publicado: (2018)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
por: Leedy, Douglas J., et al.
Publicado: (2023)

Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020)

Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation
por: Lohrmann, Graham, et al.
Publicado: (2020)

Cardiogenic Shock Due to Atrial Arrhythmia as the Initial Presentation of Transthyretin Cardiac Amyloidosis
por: Schneider, Svenja M., et al.
Publicado: (2022)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Wild type transthyretin cardiac amyloidosis in a young individual: A case report
por: Ghosh, Shreya, et al.
Publicado: (2021)

Incidence and predictors of worsening heart failure in patients with wild‐type transthyretin cardiac amyloidosis
por: Ladefoged, Bertil Thyrsted, et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Concurrent Waldenstrom Macroglobulinemia and Mutant Transthyretin Cardiac Amyloidosis
por: Qian, Xiaoxiao, et al.
Publicado: (2022)

Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
por: Yamamoto, Hiroyuki, et al.
Publicado: (2019)

The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis
por: Chaaban, Nourhan, et al.
Publicado: (2021)

Cardiac Transthyretin Amyloidosis: Hidden in Plain Sight
por: Logothetis, Constantine N., et al.
Publicado: (2021)

Spontaneous intramyocardial haematoma in transthyretin cardiac amyloidosis
por: Parizher, Gary, et al.
Publicado: (2022)

Risk stratification in transthyretin-related cardiac amyloidosis
por: Scirpa, Riccardo, et al.
Publicado: (2023)

Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2023)

Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hk6ai0f3j7q6sh0nj8avcoltmr